Trial NCT03213626

View at ClinicalTrials.gov 
Org. Study IDs: IUSCC-0597

Last trial update was posted on 2020-08-27

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Adenocarcinoma

Other Conditions

Pancreatic Adenocarcinoma Metastatic

Stopping Reasons

There were no objective responses by patient 7.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID